Last reviewed · How we verify
NCT06840912
Electroencephalographic Biofeedback Therapy in Heroin Craving
NA trial testing Pharmacological in addition to electroencephalographic (EEG) biofeedback in Electroencephalographic in 40 participants. Completed in 1 May 2024.
1 May 2024
Quick facts
| Lead sponsor | Tanta University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 40 |
| Start date | 1 February 2023 |
| Primary completion | 1 May 2024 |
| Estimated completion | 1 May 2024 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Pharmacological in addition to electroencephalographic (EEG) biofeedback
- Pharmacotherapy — full drug profile →
Conditions studied
- Electroencephalographic — all drugs for Electroencephalographic →
- Biofeedback Therapy — all drugs for Biofeedback Therapy →
- Heroin — all drugs for Heroin →
- Craving — all drugs for Craving →
Sponsor
Tanta University
Who can join
Adults 20 to 50, male only, with Electroencephalographic or Biofeedback Therapy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of this work is to assess the effectiveness of electroencephalography (EEG) biofeedback in management of heroin craving .
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06840912
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Electroencephalographic
Currently open trials in the same condition.
- NCT07339618 — Non-pharmacological Auditory and Somatosensory Stimulation in Anesthetic Emergence · NA · recruiting
Other Tanta University trials
Trials by the same sponsor.
- NCT07398651 — Apremilast and Adalimumab in Psoriatic Arthritis Patients · NA · not yet recruiting
- NCT06966856 — This Randomized, Clinical Trial Evaluates the Efficacy of Oral Versus Sublingual Vitamin B12 Supplementation in Correcti · Phase 3 · not yet recruiting
- NCT07334197 — Effect of Melatonin on Left Ventricular Reverse Remodeling and Inflammation in Peripartum Cardiomyopathy · NA · not yet recruiting
- NCT07498998 — Glucocorticoid, Ozone and 5% Dextrose Local Injection for Pain Relief in Carpal Tunnel Syndrome · NA · not yet recruiting
- NCT07114250 — Comparative Study Between Spinal Anesthesia Versus General Anesthesia in Supine Percutaneous Nephrolithotomy Operation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06840912 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tanta University
- Last refreshed: 21 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06840912.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing